Current Investing Position
Advent Life Sciences Venture Partner
Investment Range
$25K - $5.0M
Sweet Spot
$1M
Investments On Record
7
Alain Huriez is on these Sector & Stage Rankings
Alain Huriez's Investments On Record (6)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Astraveus | SeedJun 2023$18M | $18M |
Anoat Therapeutics | SeedJun 2023$2M | $2M |
ARTHEx Biotech | Series BMay 2023$46M SeedJul 2020$5M | $51M |
Calida Therapeutics | SeedApr 2023$2M | $2M |
Tridek-One | Series UnknownSep 2022$16M | $16M |
Wellium | Series UnknownMar 2020$2M | $2M |
Alain Huriez's Experience
Venture Partner Advent Life Sciences2022 - Present
Chairman & Managing Partner AdBio partners2015 - Present
President FONDATION ALBERT GLEIZES2006 - Present
Chairman of the Board Orphalan2015 - 2022
Honorary Chairman EPEMED2016 - 2021
Partner Advent Life Sciences2014 - 2021
Founder and Chairman EPEMED2009 - 2015
Chief Executive Officer TcLand (TcLand Expression & Effimune)2006 - 2012
Chief Executive Officer NEOVACS SA2003 - 2006
Associate Partner Truffle Capital2002 - 2003
Vice President Europe Biotechnology Quintiles1995 - 2002
International Project Manager - Project Director PSI CRO AG1991 - 1995
Physician- Head of Emergency Room CHU Amiens-Picardie1987 - 1991
Alain Huriez's Education
University of Paris I: Panthéon-Sorbonne Master in Pharmaco Economics
Université de Picardie Jules Verne (Amiens) Doctor of Medicine - MD
Université de Picardie Jules Verne (Amiens) Master's degree